Objective of research: to study the anthelmintic efficacy of the supramolecular complex of
Fenbendazole used against different nematode species in sheep
Materials and methods: Experiments were carried out on young sheep spontaneously
infected with gastrointestinal strongylates (48 head), Dictyocaulus filaria (42 head), Strongyloides
papillosus (21 head) и Trichocephalus ovis (24 head). In each helminthiasis, the supramolecular
complex of Fenbendazole was given once orally to sheep from various groups at the dose of 3,0;
2,0 and 1,0 mg a.i./kg in comparison with the base preparation Fenbendazole at the doses of 1,0
and 3,0 mg/kg. Sheep which didn’t receive the drug served as controls.
The efficacy of drugs was evaluated before and 18 days after dehelmintization according to the
results of coprolarvoscopic examination by flotation and G. Baermann methods. The registration
of drug activity was performed using the «control test».
Results and discussion: Anthelmintic efficacy was studied and a therapeutic dose for the
supramolecular complex of Fenbendazole produced by chemical mechanical technology using
the Drug Delivery System was determined. In gastrointestinal strongylatoses the supramolecular
complex against D. filaria. at the doses of 3,0; 2,0 and 1,0 mg a.i./kg showed the efficacy of 100;
93,4 and 78% , respectively.
The efficacy of supramolecular complex at the dose of 3,0 mg/kg against S. papillosus was
100 %, and against T. ovis - 98,3 % at 10–13% efficacy of the base preparation Fenbendazole at
the dose of 1,0 mg/kg. The therapeutic dose for the supramolecular complex at main nematodiasis
in sheep was 3,0 mg a.i./kg.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.